Research lines

  • Evaluation of new molecules effectives in the treatment of neurodegenerative diseases (Parkinson, Alzheimer, etc.)
  • Evaluation of new molecules effectives in the treatment of psycologic - psychiatric disorders (ansiolytics, sedatives, antidepressives, antipsychotics, etc.)
  • Oxidative stress and cytotoxicity
  • Vasoactive and antithrombotic drugs